As per the widely accepted 13th St Gallen International Breast Cancer Conference (2013) Expert Panel recommendations, these are referred to as luminal A-like, luminal B-like, HER2 type and triple negative-basal-like subtypes respectively, to indicate that they are proxies of the molecular subtypes [20]. Here, ERBB2 is linked to breast carcinoma.